Benchmark Maintains Buy on Strategy, Lowers Price Target to $435

Benzinga Newsdesk www.benzinga.com Negative 79.2%

Neg 79.2% Neu 0% Pos 0%

Benchmark analyst Mark Palmer maintains Strategy (NASDAQ:MSTR) with a Buy and lowers the price target from $570 to $435.